Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using a multihospital systems framework to evaluate and establish drug use policy.

L C Vermeulen1, P A Windisch, R J Rydman

  • 1Center for Drug Policy and Clinical Economics, University of Wisconsin Hospital and Clinics, Madison 53792, USA.

Journal of Medical Systems
|November 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atmospheric dispersion and transmission of Legionella from wastewater treatment plants: A 6-year case-control study.

International journal of hygiene and environmental health·2021
Same author

Climate change impacts on aflatoxin B1 in maize and aflatoxin M1 in milk: A case study of maize grown in Eastern Europe and imported to the Netherlands.

PloS one·2019
Same author

Determinants of glycaemic control in a practice setting: the role of weight loss and treatment adherence (The DELTA Study).

International journal of clinical practice·2014
Same author

The effect of amiodarone on theophylline pharmacokinetics in the rat.

Pharmaceutical research·2013
Same author

Evaluation of cardiovascular risk factors, events, and costs across four BMI categories.

Obesity (Silver Spring, Md.)·2013
Same author

Potentially lethal interaction of cimetidine and morphine.

Canadian Medical Association journal·2010

5-hydroxytryptamine subtype-3 (5-HT3) antagonists improved outcomes for chemotherapy patients with high emetic risk. For moderate to low emetic risk, conventional antiemetics were comparable, with granisetron and ondansetron showing similar effectiveness.

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Pharmacy

Background:

  • Antiemetic drug selection is crucial for managing chemotherapy-induced nausea and vomiting (CINV).
  • Hospital consortiums require evidence-based drug purchasing and use policies.
  • Comparative effectiveness of different antiemetic classes needs evaluation in real-world settings.

Purpose of the Study:

  • To evaluate antiemetic use patterns in hospitalized cancer patients receiving chemotherapy.
  • To assess the comparative effectiveness of granisetron, ondansetron, and conventional antiemetics.
  • To inform rational drug purchasing and use policies within a hospital consortium.

Main Methods:

  • Prospective, observational study across 14 academic health centers (Oct-Dec 1994).

Related Experiment Videos

  • Evaluation of antiemetic use in inpatients receiving chemotherapy agents with known emetogenic potential.
  • Measurement of clinical outcomes including patient functional status and occurrence of vomiting.

    • Main Results:

    • 5-hydroxytryptamine subtype-3 (5-HT3) antagonists (granisetron, ondansetron) were frequently prescribed.
    • 75% of 439 patients experienced no emesis.
    • 5-HT3 antagonists showed superior outcomes in patients receiving highly emetogenic chemotherapy compared to conventional antiemetics.

    Conclusions:

    • 5-HT3 antagonists are associated with better clinical outcomes for highly emetogenic chemotherapy.
    • Conventional or no antiemetic therapy provides comparable outcomes for moderate/low emetogenic chemotherapy.
    • Granisetron and ondansetron demonstrated comparable clinical effectiveness.